Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.

SZSE:301096 株式レポート

時価総額:CN¥4.3b

Hangzhou Bio-Sincerity Pharma-TechLtd 過去の業績

過去 基準チェック /16

Hangzhou Bio-Sincerity Pharma-TechLtd has been growing earnings at an average annual rate of 34.7%, while the Life Sciences industry saw earnings growing at 17.2% annually. Revenues have been growing at an average rate of 39.9% per year. Hangzhou Bio-Sincerity Pharma-TechLtd's return on equity is 7.7%, and it has net margins of 20.7%.

主要情報

34.7%

収益成長率

28.0%

EPS成長率

Life Sciences 業界の成長26.8%
収益成長率39.9%
株主資本利益率7.7%
ネット・マージン20.7%
前回の決算情報30 Sep 2024

最近の業績更新

Solid Earnings May Not Tell The Whole Story For Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096)

Apr 29
Solid Earnings May Not Tell The Whole Story For Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096)

Recent updates

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SZSE:301096) Soars 30% But It's A Story Of Risk Vs Reward

Sep 30
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SZSE:301096) Soars 30% But It's A Story Of Risk Vs Reward

Market Cool On Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s (SZSE:301096) Earnings Pushing Shares 27% Lower

Jul 24
Market Cool On Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s (SZSE:301096) Earnings Pushing Shares 27% Lower

Solid Earnings May Not Tell The Whole Story For Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096)

Apr 29
Solid Earnings May Not Tell The Whole Story For Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096)

Should You Be Adding Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096) To Your Watchlist Today?

Mar 14
Should You Be Adding Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096) To Your Watchlist Today?

収支内訳

Hangzhou Bio-Sincerity Pharma-TechLtd の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

SZSE:301096 収益、費用、利益 ( )CNY Millions
日付収益収益G+A経費研究開発費
30 Sep 241,025212120321
30 Jun 241,119287172298
31 Mar 241,072287156260
31 Dec 231,017272159240
30 Sep 23900250155203
30 Jun 23786229153184
31 Mar 23673210131164
01 Jan 23607194113163
30 Sep 2257319293149
30 Jun 2247915575120
31 Mar 2242512670110
31 Dec 213741116278
30 Sep 213041015151
30 Jun 21267854844
31 Mar 21211554636
31 Dec 20207575032
31 Dec 19156443515
31 Dec 1882112312
31 Dec 1726-7108
30 Jun 17308110
31 Mar 17275110
31 Dec 16243120
30 Sep 16211120
30 Jun 1616-1110
31 Mar 1616280
01 Jan 1616540
31 Dec 146-240

質の高い収益: 301096 has a high level of non-cash earnings.

利益率の向上: 301096's current net profit margins (20.7%) are lower than last year (27.8%).


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: 301096's earnings have grown significantly by 34.7% per year over the past 5 years.

成長の加速: 301096's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

収益対業界: 301096 had negative earnings growth (-15.3%) over the past year, making it difficult to compare to the Life Sciences industry average (-14.4%).


株主資本利益率

高いROE: 301096's Return on Equity (7.7%) is considered low.


総資産利益率


使用総資本利益率


過去の好業績企業の発掘